Related Experiment Video
Updated: Jun 18, 2025

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
Co-prevalence of chronic rhinosinusitis and inflammatory bowel disease: A large aggregated electronic health record
Ravi Dhamija1, Peng Ding2, Nikita Das1
1School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Insights
Inflammatory Bowel Disease (IBD) patients face a significantly higher risk of developing Chronic Rhinosinusitis (CRS). The study highlights a fivefold increased risk of developing CRS after an IBD diagnosis.
Area of Science:
- Gastroenterology and Immunology
- Otolaryngology
Background:
- Inflammatory Bowel Disease (IBD) and Chronic Rhinosinusitis (CRS) are distinct inflammatory conditions.
- The potential comorbidity and shared risk factors between IBD and CRS warrant investigation.
Purpose of the Study:
- To investigate the association between IBD and CRS.
- To determine the comparative risk of developing one condition after the other.
Main Methods:
- Retrospective cohort study design.
- Analysis of patient data to compare prevalence and incidence rates.
- Calculation of odds ratios and relative risks.
Main Results:
- IBD patients exhibit a 4.04-fold increased likelihood of having CRS compared to controls.
- CRS patients show a 4.23-fold increased likelihood of having IBD compared to controls.
- The risk of developing CRS subsequent to IBD is five times greater than developing IBD subsequent to CRS.
Conclusions:
- There is a strong bidirectional association between IBD and CRS.
- Patients with IBD have a significantly elevated risk of CRS.
- The temporal relationship suggests IBD may be a risk factor for CRS development.
Key Points:
IBD patients have a 4.04-fold elevated likelihood of having CRS compared to non-IBD patients. CRS patients have a 4.23-fold elevated likelihood of having IBD compared to non-CRS patients. The risk of CRS development after IBD is five times higher than IBD development after CRS.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

